A study to learn how well enfortumab vedotin (EV) with pembrolizumab works and how safe it is in people with advanced urothelial cancer: a plain language summary of the EV-302/KEYNOTE-A39 study.
Journal: Future Oncology (London, England)
Published:
Authors
Thomas Powles, Begoña Valderrama, Shilpa Gupta, Jens Bedke, Eiji Kikuchi, Jean Hoffman Censits, Gopa Iyer, Christof Vulsteke, Se Park, Sang Shin, Daniel Castellano, Giuseppe Fornarini, Jian-ri Li, Mahmut Gümüş, Nataliya Mar, Yohann Loriot, Aude Fléchon, Ignacio Duran, Alexandra Drakaki, Sujata Narayanan, Xuesong Yu, Seema Gorla, Blanca Homet Moreno, Michiel Van Der Heijden